نتایج جستجو برای: intermittent bolus doses

تعداد نتایج: 151841  

Journal: :Obstetrics and gynecology 2004
José C A Carvalho Mrinalini Balki John Kingdom Rory Windrim

OBJECTIVE Oxytocin is frequently used by intravenous bolus and infusion to minimize blood loss and prevent postpartum hemorrhage at cesarean delivery. Current dosing regimens are arbitrary whereas large doses may pose a serious risk to the mother. The purpose of this study was to estimate the minimum effective intravenous bolus dose of oxytocin (ED90) required for adequate uterine contraction a...

Journal: :Rheumatology 2003
J D Ringe A Dorst H Faber K Ibach J Preuss

OBJECTIVE Corticosteroids are widely prescribed, although treatment-related side-effects are common. Of these adverse events (AEs), osteoporosis is considered the most serious. Currently, oral bisphosphonates are the standard treatment for corticosteroid-induced osteoporosis (CIO). However, intermittent intravenous (i.v.) therapy may have advantages, including lack of gastrointestinal AEs, impr...

2006
Arlene A. Forastiere James F. Belliveau Marshall P. Goren Walter C. Vogel Marshall R. Posner Gerard P. O'Leary

We administered cis-diamminedichloroplatinum(II), 30 my/iir/day for 5 days by continuous infusion to six patients with head and neck cancer, and compared the total and filterable plasma concentrations of platinum, and toxic effects, with those observed in five additional patients who received the same dose and schedule of cij-diamminedichloroplatinum(II) by intermittent bolus. In the continuous...

Journal: :Cancer research 1988
A A Forastiere J F Belliveau M P Goren W C Vogel M R Posner G P O'Leary

We administered cis-diamminedichloroplatinum(II), 30 mg/m2/day for 5 days by continuous infusion to six patients with head and neck cancer, and compared the total and filterable plasma concentrations of platinum, and toxic effects, with those observed in five additional patients who received the same dose and schedule of cis-diamminedichloroplatinum(II) by intermittent bolus. In the continuous ...

2010
Maria Soledad Cepeda Mila Etropolski Rachel Weinstein Daniel Fife Raymond Boston Amy Matcho

BACKGROUND Little data exist on how opioid doses vary with the length of exposure among chronic opioid users. METHODS To characterize the change in the dosage of opioids over time, a retrospective cohort study using the PharMetrics database for the years 1999 through 2008 was conducted. Individuals exposed to opioids in 2000 who had 2 opioid dispensings at least 6 months apart and were opioid...

Journal: :Blood 1996
M J Stone E A Sausville J W Fay D Headlee R H Collins W D Figg M Stetler-Stevenson V Jain E S Jaffe D Solomon R M Lush A Senderowicz V Ghetie J Schindler J W Uhr E S Vitetta

IgG-HD37-SMPT-dgA is a deglycosylated ricin A chain (dgA)-containing immunotoxin (IT) prepared by conjugating the monoclonal murine (MoAb) anti-CD19 antibody, HD37, to dgA using the heterobifunctional hindered disulfide linker, N-succinimidyl-oxycarbonyl-alpha-methyl-alpha-(2-pyridyldithio) toluene (SMPT). In this report, we have used two regimens for the administration of IgG-HD37-SMPT-dgA to ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید